Columbia, MD, United States of America

Benjamin L Wolozin

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin L. Wolozin

Introduction

Benjamin L. Wolozin is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of neuroscience, particularly in the diagnosis of Alzheimer's disease. His work focuses on the development of human olfactory neuron cultures, which have the potential to revolutionize the way we understand and diagnose neurodegenerative diseases.

Latest Patents

Wolozin holds a patent for "Human olfactory neuron cultures to diagnose Alzheimer's disease." This invention relates to a culture of human olfactory neurons that may exhibit either normal neuronal pathology or a pathology characteristic of generalized central nervous system diseases. The cultured neurons can be utilized for neurotoxicity tests, screening for therapeutic drugs and anti-viral agents, and diagnosing Alzheimer's disease. He has 1 patent to his name.

Career Highlights

Wolozin is affiliated with the United States of America as represented by the Department of Health. His work has garnered attention for its innovative approach to addressing critical health issues. His research has the potential to lead to breakthroughs in the diagnosis and treatment of Alzheimer's disease.

Collaborations

Wolozin collaborates with Hayden G. Coon, contributing to the advancement of research in the field of neuroscience. Their combined efforts aim to enhance the understanding of neurodegenerative diseases and improve diagnostic methods.

Conclusion

Benjamin L. Wolozin's innovative work in developing human olfactory neuron cultures represents a significant advancement in the field of neuroscience. His contributions have the potential to improve the diagnosis and treatment of Alzheimer's disease, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…